Figure 3.
Proportion of allergy-related adverse events following immunisation (AEFI) with trivalent influenza vaccines, by week from reporting commencement, Victoria, 2008–2015 (n = 1,010 total AEFI)
AEFI: adverse events following immunisation.
The y axis shows the proportion of allergy-related AEFI at the end of seasonal vaccination campaign.